Canada: Researchers have found in a new study that younger individuals who survive acute myocardial infarction (AMI) and live ...

New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

For younger acute myocardial infarction survivors, living in marginalized neighborhoods is associated with adverse outcomes.

UC Davis Medical Center earned four awards from the American Heart Association for its optimal care for heart and stroke patientsThese awards are part ...

Better prevention and emergency cardiovascular care have dramatically reduced heart attack deaths, but other heart conditions like heart failure and arrhythmias are claiming more lives.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

THE Philippine Health Insurance Corp. (PhilHealth) said on Wednesday that member contribution rates will not rise because they are fixed by law, adding that it will seek to offset the loss of ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Patients with overweight or obesity and heart failure with preserved ejection fraction that have unintentional weight loss have worse outcomes.

With support from the National Institutes of Health, a University of Texas at Arlington bioengineering professor is ...

US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...